vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and Shoals Technologies Group, Inc. (SHLS). Click either name above to swap in a different company.

HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $148.3M, roughly 1.8× Shoals Technologies Group, Inc.). Shoals Technologies Group, Inc. runs the higher net margin — 5.5% vs 0.7%, a 4.8% gap on every dollar of revenue. On growth, Shoals Technologies Group, Inc. posted the faster year-over-year revenue change (38.6% vs -16.5%). HUTCHMED (China) Ltd produced more free cash flow last quarter ($3.4M vs $-11.3M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

Shoals Technologies Group is a leading provider of electrical balance of systems solutions for renewable energy and e-mobility. It supplies connectivity components for solar projects, energy storage systems and EV charging infrastructure, serving clients across North America, Europe and Asia-Pacific.

HCM vs SHLS — Head-to-Head

Bigger by revenue
HCM
HCM
1.8× larger
HCM
$270.8M
$148.3M
SHLS
Growing faster (revenue YoY)
SHLS
SHLS
+55.2% gap
SHLS
38.6%
-16.5%
HCM
Higher net margin
SHLS
SHLS
4.8% more per $
SHLS
5.5%
0.7%
HCM
More free cash flow
HCM
HCM
$14.6M more FCF
HCM
$3.4M
$-11.3M
SHLS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCM
HCM
SHLS
SHLS
Revenue
$270.8M
$148.3M
Net Profit
$2.0M
$8.1M
Gross Margin
37.7%
31.6%
Operating Margin
-13.2%
11.7%
Net Margin
0.7%
5.5%
Revenue YoY
-16.5%
38.6%
Net Profit YoY
-83.6%
3.9%
EPS (diluted)
$0.00
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
SHLS
SHLS
Q4 25
$270.8M
$148.3M
Q3 25
$135.8M
Q2 25
$277.7M
$110.8M
Q1 25
$324.5M
$80.4M
Q4 24
$107.0M
Q3 24
$102.2M
Q2 24
$305.7M
$99.2M
Q1 24
$90.8M
Net Profit
HCM
HCM
SHLS
SHLS
Q4 25
$2.0M
$8.1M
Q3 25
$11.9M
Q2 25
$455.0M
$13.9M
Q1 25
$11.9M
$-282.0K
Q4 24
$7.8M
Q3 24
$-267.0K
Q2 24
$25.8M
$11.8M
Q1 24
$4.8M
Gross Margin
HCM
HCM
SHLS
SHLS
Q4 25
37.7%
31.6%
Q3 25
37.0%
Q2 25
0.1%
37.2%
Q1 25
48.0%
35.0%
Q4 24
37.6%
Q3 24
24.8%
Q2 24
41.1%
40.3%
Q1 24
40.2%
Operating Margin
HCM
HCM
SHLS
SHLS
Q4 25
-13.2%
11.7%
Q3 25
13.7%
Q2 25
-1.3%
14.4%
Q1 25
-5.0%
5.4%
Q4 24
15.4%
Q3 24
4.4%
Q2 24
-9.0%
18.7%
Q1 24
12.8%
Net Margin
HCM
HCM
SHLS
SHLS
Q4 25
0.7%
5.5%
Q3 25
8.7%
Q2 25
163.8%
12.5%
Q1 25
3.7%
-0.4%
Q4 24
7.3%
Q3 24
-0.3%
Q2 24
8.4%
11.9%
Q1 24
5.3%
EPS (diluted)
HCM
HCM
SHLS
SHLS
Q4 25
$0.00
$0.05
Q3 25
$0.07
Q2 25
$0.52
$0.08
Q1 25
$0.01
$0.00
Q4 24
$0.04
Q3 24
$0.00
Q2 24
$0.03
$0.07
Q1 24
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
SHLS
SHLS
Cash + ST InvestmentsLiquidity on hand
$1.4B
$7.3M
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$1.2B
$600.0M
Total Assets
$1.8B
$904.1M
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
SHLS
SHLS
Q4 25
$1.4B
$7.3M
Q3 25
$8.6M
Q2 25
$1.4B
$4.7M
Q1 25
$836.1M
$35.6M
Q4 24
$23.5M
Q3 24
$11.1M
Q2 24
$802.5M
$3.2M
Q1 24
$15.2M
Total Debt
HCM
HCM
SHLS
SHLS
Q4 25
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
$141.8M
Q4 24
$141.8M
Q3 24
$141.8M
Q2 24
$82.1M
$146.8M
Q1 24
$168.8M
Stockholders' Equity
HCM
HCM
SHLS
SHLS
Q4 25
$1.2B
$600.0M
Q3 25
$589.6M
Q2 25
$1.2B
$575.4M
Q1 25
$759.9M
$558.9M
Q4 24
$556.8M
Q3 24
$545.2M
Q2 24
$740.1M
$544.6M
Q1 24
$554.0M
Total Assets
HCM
HCM
SHLS
SHLS
Q4 25
$1.8B
$904.1M
Q3 25
$851.8M
Q2 25
$1.8B
$795.0M
Q1 25
$1.3B
$788.4M
Q4 24
$793.1M
Q3 24
$801.3M
Q2 24
$1.3B
$788.4M
Q1 24
$825.3M
Debt / Equity
HCM
HCM
SHLS
SHLS
Q4 25
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
0.25×
Q4 24
0.25×
Q3 24
0.26×
Q2 24
0.11×
0.27×
Q1 24
0.30×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
SHLS
SHLS
Operating Cash FlowLast quarter
$8.2M
$-4.1M
Free Cash FlowOCF − Capex
$3.4M
$-11.3M
FCF MarginFCF / Revenue
1.2%
-7.6%
Capex IntensityCapex / Revenue
1.8%
4.8%
Cash ConversionOCF / Net Profit
4.21×
-0.50×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M
$-16.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
SHLS
SHLS
Q4 25
$8.2M
$-4.1M
Q3 25
$19.4M
Q2 25
$-72.9M
$-13.8M
Q1 25
$40.3M
$15.6M
Q4 24
$14.0M
Q3 24
$15.7M
Q2 24
$-39.8M
$37.8M
Q1 24
$12.9M
Free Cash Flow
HCM
HCM
SHLS
SHLS
Q4 25
$3.4M
$-11.3M
Q3 25
$9.0M
Q2 25
$-82.2M
$-26.0M
Q1 25
$32.5M
$12.3M
Q4 24
$12.5M
Q3 24
$13.3M
Q2 24
$-49.9M
$35.8M
Q1 24
$10.4M
FCF Margin
HCM
HCM
SHLS
SHLS
Q4 25
1.2%
-7.6%
Q3 25
6.6%
Q2 25
-29.6%
-23.5%
Q1 25
10.0%
15.4%
Q4 24
11.6%
Q3 24
13.0%
Q2 24
-16.3%
36.1%
Q1 24
11.4%
Capex Intensity
HCM
HCM
SHLS
SHLS
Q4 25
1.8%
4.8%
Q3 25
7.7%
Q2 25
3.3%
11.0%
Q1 25
2.4%
4.0%
Q4 24
1.4%
Q3 24
2.3%
Q2 24
3.3%
2.0%
Q1 24
2.7%
Cash Conversion
HCM
HCM
SHLS
SHLS
Q4 25
4.21×
-0.50×
Q3 25
1.63×
Q2 25
-0.16×
-1.00×
Q1 25
3.38×
Q4 24
1.79×
Q3 24
Q2 24
-1.54×
3.21×
Q1 24
2.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCM
HCM

Segment breakdown not available.

SHLS
SHLS

System Solutions$122.0M82%
Components$26.3M18%

Related Comparisons